Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EscharEx in Venous Leg Ulcers
NCT06690177Phase 2Not yet recruiting
- Sponsor
- MediWound
- Start
- Jan 2027
- Primary completion
- Nov 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of EscharEx in venous leg ulcer (VLU), sponsored by MediWound. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
EscharEx
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT06690177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06690177.